prof. dr hab. Irena Nalepa
Strona główna
/
Instytut
/
Pracownicy
/
prof. dr hab. Irena Nalepa

prof. dr hab. Irena Nalepa
Dokonania naukowe
- Publikacje
Suppression of pro-inflammatory cytokine expression and lack of anti-depressant-like effect of fluoxetine in lipopolysaccharide-treated old female mice
Autorzy: Duda, W., Kubera, M., Kreiner, G., Curzytek, K., Detka, J., Głombik, K., Ślusarczyk, J., Basta-Kaim, A., Budziszewska, B., Lasoń, W., Regulska, M., Leśkiewicz, M., Roman, A., Zelek-Molik, A., Nalepa, I.
DOI: 10.1016/j.intimp.2017.04.021
Date: 2017-01-01
Transgenic mice lacking CREB and CREM in noradrenergic and serotonergic neurons respond differently to common antidepressants on tail suspension test
Autorzy: Rafa-Zabłocka, K., Kreiner, G., Bagińska, M., Kuśmierczyk, J., Parlato, R., Nalepa, I.
DOI: 10.1038/s41598-017-14069-6
Date: 2017-01-01
Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target – Evidence from a mouse diabetic neuropathy model
Autorzy: Zychowska, M., Rojewska, E., Piotrowska, A., Kreiner, G., Nalepa, I., Mika, J.
DOI: 10.1016/j.intimp.2017.09.021
Date: 2017-01-01
Depressive-like effect of prenatal exposure to DDT involves global DNA hypomethylation and impairment of GPER1/ESR1 protein levels but not ESR2 and AHR/ARNT signaling
Autorzy: Kajta, M., Wnuk, A., Rzemieniec, J., Litwa, E., Lason, W., Zelek-Molik, A., Nalepa, I., Rogóż, Z., Grochowalski, A., Wojtowicz, A.K.
DOI: 10.1016/j.jsbmb.2017.03.001
Date: 2017-01-01
Lack of riluzole efficacy in the progression of the neurodegenerative phenotype in a new conditional mouse model of striatal degeneration
Autorzy: Kreiner, G., Rafa-Zabłocka, K., Chmielarz, P., Bagińska, M., Nalepa, I.
DOI: 10.7717/peerj.3240
Date: 2017-01-01
A lack of α<inf>1A</inf>-adrenergic receptor-mediated antidepressant-like effects of S-(+)-niguldipine and B8805-033 in the forced swim test
Autorzy: Kreiner, G., Roman, A., Zelek-Molik, A., Kowalska, M., Nalepa, I.
DOI: 10.1097/FBP.0000000000000204
Date: 2016-01-01
Erratum to: Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease (Neurotox Res, (2016), 29, (351-363), 10.1007/s12640-015-9556-6)
Autorzy: Wasik, A., Romańska, I., Michaluk, J., Zelek-Molik, A., Nalepa, I., Antkiewicz-Michaluk, L.
DOI: 10.1007/s12640-016-9622-8
Date: 2016-01-01
Depressive-like immobility behavior and genotype × stress interactions in male mice of selected strains
Autorzy: Chmielarz, P., Kreiner, G., Kuśmierczyk, J., Kowalska, M., Roman, A., Tota, K., Nalepa, I.
DOI: 10.3109/10253890.2016.1150995
Date: 2016-01-01
Imipramine administration induces changes in the phosphorylation of FAK and PYK2 and modulates signaling pathways related to their activity
Autorzy: Zalewska, T., Bielawski, A., Stanaszek, L., Wieczerzak, K., Ziemka-Nałęcz, M., Nalepa, I.
DOI: 10.1016/j.bbagen.2015.11.008
Date: 2016-01-01
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson’s Disease
Autorzy: Wąsik, A., Romańska, I., Michaluk, J., Zelek-Molik, A., Nalepa, I., Antkiewicz-Michaluk, L.
DOI: 10.1007/s12640-015-9556-6
Date: 2016-01-01